ATC codes:
L01DB01
EMLc
Indication
Malignant neoplasms of kidney, except renal pelvis
ICD11 code:
2D40.Z
INN
Doxorubicin
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
10 mg in vial (hydrochloride) powder for injection ;
50 mg in vial (hydrochloride) powder for injection ;
2 mg per mL in 5 mL vial (hydrochloride) ;
2 mg per mL in 25 mL vial (hydrochloride)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the inclusion of an additional dose forms of doxorubicin (2 mg/mL (hydrochloride) in 5 mL, 25 mL vial) to the EML and EMLc.